capivasertib vs pan-mutant-selective pi3k-alpha inhibitor rly-5836
| capivasertib | pan-mutant-selective pi3k-alpha inhibitor rly-5836 | |
|---|---|---|
| Developers | 0 | 0 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | CAPIVASERTIB | Pan-mutant-selective PI3K-alpha Inhibitor RLY-5836 |